Effects of anesthesia upon18F-FDG uptake in rhesus monkey brains

The kinetics of18F-fluorodeoxyglucose (18F-FDG) in the monkey brain were monitored, and comparisons were made between the conscious state and when under ketamine and pentobarbital anesthesia. Rhesus monkeys were intravenously injected with18F-FDG and followed by 60 min of PET scanning. In the conscious state, the18F-FDG concentration reached a plateau 5 min after intravenous injection. Under ketamine anesthesia, the18F-FDG concentration gradually increased with time in all monitored regions. At 60 min after injection, the concentration in the striatum was about 3.2 times greater than that in the conscious state, and about 4.5 times greater in the cerebral cortex. Under pentobarbital anesthesia, the18F-FDG concentration in the occipital cortex was slightly lower. These findings demonstrate that18F-FDG concentration in the monkey brain is significantly affected by anesthesia. The results also imply the existence of a short-term regulation mechanism for hexokinase activity in intact monkey brain.

[1]  A. Cornish-Bowden,et al.  Allosteric character of the inhibition of rat-muscle hexokinase B by glucose 6-phosphate. , 1986, European journal of biochemistry.

[2]  P. Grasby,et al.  Effects of the 5-HT1A partial agonists gepirone, ipsapirone and buspirone on local cerebral glucose utilization in the conscious rat , 2005, Psychopharmacology.

[3]  Karl Herholz,et al.  PET studies in dementia , 2003, Annals of nuclear medicine.

[4]  Abass Alavi,et al.  18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. , 2002, Seminars in nuclear medicine.

[5]  Acute effect of 3-(4-acetamido)-butyrril-lorazepam (DDS2700) on brain function assessed by PET at rest and during attentive tasks , 2001, Nuclear medicine communications.

[6]  R. Mailman,et al.  Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation , 1998, Brain Research.

[7]  G. Duncan,et al.  Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. , 2000, The Journal of pharmacology and experimental therapeutics.

[8]  Takashi Kato,et al.  Rat‐PET study without anesthesia: Anesthetics modify the dopamine D1 receptor binding in rat brain , 2004, Synapse.

[9]  Seiya Miyamoto,et al.  Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine , 1999, Brain Research.

[10]  H. Onoe,et al.  Difference in response of D2 receptor binding between11C-N-methylspiperone and11C-raclopride against anesthetics in rhesus monkey brain , 2005, Journal of Neural Transmission / General Section JNT.

[11]  P. Enblad,et al.  A metabolic threshold of irreversible ischemia demonstrated by PET in a middle cerebral artery occlusion–reperfusion primate model* , 2000, Acta neurologica Scandinavica.

[12]  B. Weber,et al.  Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  R. Post,et al.  Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. , 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[14]  R. Parsey,et al.  Applications of positron emission tomography in psychiatry. , 2003, Seminars in nuclear medicine.

[15]  P. Ell,et al.  Clinical role of positron emission tomography in oncology. , 2001, The Lancet. Oncology.

[16]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[17]  S. Potkin,et al.  Clozapine effects on glucose metabolic rate in striatum and frontal cortex. , 1994, The Journal of clinical psychiatry.

[18]  J. Pratt,et al.  Local cerebral glucose utilization following subacute and chronic diazepam pretreatment: differential tolerance , 1989, Brain Research.

[19]  C. Patlak,et al.  Pentobarbital produces dissimilar changes in glucose influx and utilization in brain. , 1991, The American journal of physiology.

[20]  F. Fazio,et al.  In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  George Segall,et al.  Assessment of myocardial viability by positron emission tomography , 2002, Nuclear medicine communications.

[22]  D. Lodge,et al.  The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate , 1983, British Journal of Pharmacology.

[23]  H. Onoe,et al.  Brain activation study by use of positron emission tomography in unanesthetized monkeys , 1994, Neuroscience Letters.

[24]  H. Petty,et al.  Hexokinase translocation during neutrophil activation, chemotaxis, and phagocytosis: disruption by cytochalasin D, dexamethasone, and indomethacin. , 2002, Cellular immunology.

[25]  M Masellis,et al.  D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine , 2003, Molecular Psychiatry.

[26]  Florence Mézenge,et al.  Effects of Damage to the Basal Forebrain on Brain Glucose Utilization: A Reevaluation Using Positron Emission Tomography in Baboons with Extensive Unilateral Excitotoxic Lesion , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.